| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023218 Purified nucleic acid molecule for the expression of a lysosomal enzyme and use thereof for preventing or treating lysosomal storage diseases |
| 02/05/2004 | US20040023215 Methods and compositions employing the nucleic acids, polypeptides or peptides, antibodies, and/or ligands for use in diagnostics and therapeutics for asthma and other diseases |
| 02/05/2004 | US20040023207 Assays for screening compounds based on their effectiveness in modulating such microcompetition; effective compounds can be used in treatment of these chronic diseases |
| 02/05/2004 | US20040023204 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/05/2004 | US20040022869 Containing microtubule stabilizing agents and one or more heat shock protein (HSP)-inducing agents; treating a proliferative disorder, an infectious disease, a cardiovascular disease, an autoimmune disorder, or an inflammatory disorder |
| 02/05/2004 | US20040022812 Herpes viruses for immune modulation |
| 02/05/2004 | US20040022799 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 02/05/2004 | US20040022791 Use of the heavy chain of an antibody, of a functional derivative, or of a fragment thereof, comprising a CDR3 region for jointly inhibiting fibrinogen binding to platelets and vitronectin binding to endothelial cells |
| 02/05/2004 | US20040022790 CNS neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022774 Fibrocyte-based vaccine formulations |
| 02/05/2004 | US20040022768 Process useful for producing selective immune down regulation (SIDR) in subjects, including adult subjects to artificially expressed gene, gene delivery systems, infectious agents, and non-cellular immunogenic components, and processes for producing immunological tolerance in subjets using SIDR |
| 02/05/2004 | US20040022766 Administering by subretinal injection an effective amount of recombinant adeno-associated virus carrying a nucleic acid sequence encoding normal gene under the control of promoter sequence which expresses the product of gene in ocular cells |
| 02/05/2004 | US20040022764 Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease |
| 02/05/2004 | DE10233064A1 gM-negative EHV-Mutanten ohne heterologe Elemente gM-negative EHV mutants without heterologous elements |
| 02/05/2004 | CA2518732A1 Assays and methods based on microcompetition with a foreign polynucleotide |
| 02/05/2004 | CA2493584A1 Inhibition of stearoyl-coa desaturase 1 (scd1) increases insulin sensitivity and treats diabetes |
| 02/05/2004 | CA2492463A1 Regulated aptamer therapeutics |
| 02/05/2004 | CA2401567A1 Methods of preventing the inhibition of apoptosis and treating inflammatory conditions |
| 02/04/2004 | EP1386973A1 Method of estimating diplotype from genotype of individual |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386615A1 EG-VEGF/Prokineticin 2 receptor antagonists |
| 02/04/2004 | EP1386162A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1386004A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies |
| 02/04/2004 | EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 02/04/2004 | EP1385987A2 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385969A2 Viral vector system to transduce or infect a target adipose tissue site |
| 02/04/2004 | EP1385962A2 Human prolyl 4-hydroxylases |
| 02/04/2004 | EP1385952A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 02/04/2004 | EP1385948A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 02/04/2004 | EP1385945A1 Novel mutation |
| 02/04/2004 | EP1385937A1 Delivery of polynucleotide agents to the central nervous sysstem |
| 02/04/2004 | EP1385934A2 Pufa polyketide synthase systems and uses thereof |
| 02/04/2004 | EP1385884A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385873A2 A ligand for enhancing oral and cns delivery of biological agents |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385861A2 Compositions and methods relating to lung specific genes and proteins |
| 02/04/2004 | EP1385555A1 Viral vectors having reduced virulence |
| 02/04/2004 | EP1385538A2 Chimeric vaccines |
| 02/04/2004 | EP1385452A1 Ophthalmic drug delivery device |
| 02/04/2004 | EP0938578B1 Genetic modification of primate hemopoietic repopulating stem cells |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0730404B1 Amphiphilic imidazolinium derivatives |
| 02/04/2004 | CN1473051A Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1472325A Cardiac atrium peptide gene transfecting cell microcapsule |
| 02/04/2004 | CN1471977A Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases |
| 02/04/2004 | CN1137262C Mutants of Rb and P53 genes and uses thereof |
| 02/04/2004 | CN1136920C Gene transfer-mediated angiogenesis therapy |
| 02/04/2004 | CN1136914C Method for identifying or isolating molecule and molecules identified therby |
| 02/03/2004 | US6687428 Optical switch |
| 02/03/2004 | US6686196 Useful for regulating transgene expression in cells such as tumor cells and therefore, for therapy of a variety of cancers |
| 02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
| 02/03/2004 | US6686163 Coding sequence haplotype of the human BRCA1 gene |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6686148 Methods for targeting RNA molecules |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685938 Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases |
| 02/03/2004 | US6685935 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 01/29/2004 | WO2004009836A2 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/29/2004 | WO2004009824A2 Pav regions for encapsidation and e1 transcriptioonal control |
| 01/29/2004 | WO2004009811A1 A gene entrain system with the core sequence of histone |
| 01/29/2004 | WO2004009802A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 01/29/2004 | WO2004009792A2 Transposon-based vectors and methods of nucleic acid integration |
| 01/29/2004 | WO2004009790A2 Metastatic colon cancer specific promoter and uses thereof |
| 01/29/2004 | WO2004009788A2 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 01/29/2004 | WO2004009766A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009636A2 Gnrh modulator |
| 01/29/2004 | WO2004009634A2 Novel polypeptides and nucleic acids encoding same |
| 01/29/2004 | WO2004009541A2 Antisense modulation of endothelial lipase expression |
| 01/29/2004 | WO2004009131A1 Tumor treating combinations, compositions and methods |
| 01/29/2004 | WO2004009130A1 Tumor treating composition and methods |
| 01/29/2004 | WO2004009129A1 Method and compositions for treatment of bone disorders |
| 01/29/2004 | WO2004009123A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | WO2004009113A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 01/29/2004 | WO2004009112A1 Use of urease for inhibiting cancer cell growth |
| 01/29/2004 | WO2004009024A2 Modulation of protein kinase c-iota expression |
| 01/29/2004 | WO2004009022A2 Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| 01/29/2004 | WO2004009018A2 Antisense modulation of ptprm expression |
| 01/29/2004 | WO2003095485A3 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 01/29/2004 | WO2003059932A3 Methods of inducing or enhancing connective tissue repair |
| 01/29/2004 | WO2003050241A3 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003047634A3 Nucleic acids and methods for treating ebv-positive cancers |
| 01/29/2004 | WO2003047631A3 Clasp-pna-conjugate for the specific transport of nucleic acids which are thermally active |
| 01/29/2004 | WO2003039489A3 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 01/29/2004 | WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 01/29/2004 | WO2003017944A3 Gpi-anchored cytokines |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002095001A3 Btf3: an inhibitor of apoptosis |
| 01/29/2004 | WO2002086134B1 Buffer solution for electroporation and a method comprising the use of the same |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain |